| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2009 | US20090137633 Stable pharmaceutical composition of rabeprazole |
| 05/28/2009 | US20090137632 Compositions And Methods For Treating Dyslipidemia |
| 05/28/2009 | US20090137631 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 05/28/2009 | US20090137630 trans-R,R-2-chlorine-3N-(3a,4,5,6,7,7a-hexahydro-1H-2-benzimidazolyl)-4-methyl-3-thienylamine, having inhibitory properties on transport proteins, useful for treating respiratory system and nervous system disorders, ischemia, reperfusion injuries, fibrosis, diabetes, blood coagulation and infections |
| 05/28/2009 | US20090137629 Sigma receptor binding agent containing indanone derivative |
| 05/28/2009 | US20090137628 Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic Pain |
| 05/28/2009 | US20090137627 Method for Treating Chronic Pain |
| 05/28/2009 | US20090137626 Pharmaceutical Composition Containing PPARgamma Agonist |
| 05/28/2009 | US20090137625 Novel Enantiomers and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors |
| 05/28/2009 | US20090137624 anticancer agents; tyrosine kinase inhibitors based on pyrazole-3-amine linked through amine to fused heterocyclic ring such as benzimidazole, or imidazo[4,5-b]pyridine; e.g. N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-(1-(4-fluorophenyl)ethyl)-3H-imidazo[4,5-b]pyridin-5-amine |
| 05/28/2009 | US20090137623 Muscarinic receptor antagonists |
| 05/28/2009 | US20090137622 Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 05/28/2009 | US20090137621 Capsules Containing Inhalable Tiotropium |
| 05/28/2009 | US20090137620 Use of gallium(iii) complexes for the treatment of melanomas |
| 05/28/2009 | US20090137619 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent |
| 05/28/2009 | US20090137618 Pro-drugs for controlled release of biologically active compounds |
| 05/28/2009 | US20090137617 Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular disease |
| 05/28/2009 | US20090137615 Indazolylamino quinazoline derivatives as antitumour agents |
| 05/28/2009 | US20090137614 Pharmaceutical combination comprising vitamin k |
| 05/28/2009 | US20090137613 Pharmaceutically acceptable salts and polymorphic forms |
| 05/28/2009 | US20090137612 Treatment with combined use of oxypurines and ascorbate to prevent and mitigate iron-catalized oxidative damage in Alzheimer's disease and other neurodegenerative disorders |
| 05/28/2009 | US20090137610 Spiro imidozole derivatives as ppar modulators |
| 05/28/2009 | US20090137609 Vitamin d-like compound |
| 05/28/2009 | US20090137608 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor |
| 05/28/2009 | US20090137607 6-phenyl-7-(4-{[4-(3-pyridin-2-yl-1,2,4-triazol-5-yl)piperidin-1-yl]methyl}phenyl)imidazo[1,2a]-pyrimidine; phosphatidyl inositol 3-kinase inhibitors; anticancer agents; apoptosis |
| 05/28/2009 | US20090137606 Chewable formulations |
| 05/28/2009 | US20090137605 providing alcoholic solvent, desolventizing to form solid mass, isolating amorphous form; psychosis |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137603 Heterocyclic amide compound and use thereof |
| 05/28/2009 | US20090137602 Combination preparation against vertigo |
| 05/28/2009 | US20090137601 L-Phenylalanine Derivatives |
| 05/28/2009 | US20090137600 Antiplatelet agent and process for producing the same |
| 05/28/2009 | US20090137599 Methods of identifying responders to dopamine agonist therapy |
| 05/28/2009 | US20090137598 Method of treating metabolic disorders and depression with dopamine receptor agonists |
| 05/28/2009 | US20090137597 Novel quinoxalinone derivatives |
| 05/28/2009 | US20090137596 G-protein inhibitor |
| 05/28/2009 | US20090137595 Fused heterocyclic derivative and use thereof |
| 05/28/2009 | US20090137594 Pentafluorosulphanyl-Substituted Compound And Its Use For Producing Medicaments |
| 05/28/2009 | US20090137593 4-amino-2,6-dimethylphenol compound, process for its preparation and pharmaceutical composition comprising the same |
| 05/28/2009 | US20090137592 Morpholines as selective inhibitors of cytochrome p450 2a13 |
| 05/28/2009 | US20090137591 Compounds and compositions as ppar modulators |
| 05/28/2009 | US20090137590 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| 05/28/2009 | US20090137589 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses |
| 05/28/2009 | US20090137588 Heteroaryl compounds and uses thereof |
| 05/28/2009 | US20090137587 4-[(4-Chlorobenzyl)oxy]-1-(4-[(1E)-3-(methylamino)-1-propen-1-yl]phenyl)pyridin-2(1H)-one; remedy for metabolic disorders such as obesity, diabetes, hormone disorder; cardiovascular disorders (stenocardia, acute or congestive heart failure); nervous system disorders (bulimia, anxiety, epilepsy etc.) |
| 05/28/2009 | US20090137586 Compounds for the treatment of inflammatory disorders |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/28/2009 | US20090137584 Sulfonyl benzimidazole derivatives |
| 05/28/2009 | US20090137583 2-aminoquinazoline derivatives |
| 05/28/2009 | US20090137582 Pyrazolo-pyridinone derivatives and methods of use |
| 05/28/2009 | US20090137581 Heterocyclic compounds and their uses |
| 05/28/2009 | US20090137580 Fused Heterocyclic Derivatives and Use Thereof |
| 05/28/2009 | US20090137579 Mesylate salt of an IKK inhibitor |
| 05/28/2009 | US20090137578 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| 05/28/2009 | US20090137577 Heterocyclic compounds |
| 05/28/2009 | US20090137576 Novel Piperidine Derivative |
| 05/28/2009 | US20090137575 Fused Tetracyclic mGluR1 Antagonists as Therapeutic Agents |
| 05/28/2009 | US20090137574 Combination Therapy Using an 11Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders |
| 05/28/2009 | US20090137573 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments |
| 05/28/2009 | US20090137572 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders |
| 05/28/2009 | US20090137571 2-Cyclopentyl-N-(2-bromo-6-trifluoromethyl-4-(thio)morpholin-4-yl-phenyl)-acetamide;potent openers of the KCNQ family of potassium ion channels; antiepileptic agents;anticonvulsants; anxiolytic agents; neurodegenerative disorders; analgesics for headaches, neuropathic pain; bipolar disorders |
| 05/28/2009 | US20090137570 Inhibitors of cathepsin s |
| 05/28/2009 | US20090137569 Administration of (3S)-N-hydroxy-4-(sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (S)-N_hydroxy-4-[4_(but-2-ynyloxy)phenylsulfonyl]-2,2-dimethyl thimomorpholine-3-carboxamide for preventing and/or treating inflammatory skin pathologies/afflictions |
| 05/28/2009 | US20090137568 Tryclic Nitrogen Containing Compounds and their Use as Antibacterials |
| 05/28/2009 | US20090137567 Methods for Treating Blood Disorders |
| 05/28/2009 | US20090137566 Substituted Piperdines as Renin Inhibitors |
| 05/28/2009 | US20090137565 Method for treatment of movement disorders |
| 05/28/2009 | US20090137564 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, A Process for Their Production and Their Use as Anti-inflammatory Agents |
| 05/28/2009 | US20090137563 Process for the prepartion of olanzapine |
| 05/28/2009 | US20090137562 Substituted benzyl amine compounds |
| 05/28/2009 | US20090137561 Substituted biphenyl GPR40 modulators |
| 05/28/2009 | US20090137560 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 05/28/2009 | US20090137559 Bazedoxifene ascorbate |
| 05/28/2009 | US20090137558 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 05/28/2009 | US20090137557 Calcilytic Compounds |
| 05/28/2009 | US20090137556 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists |
| 05/28/2009 | US20090137555 activity of CDK1, CDK2, CDK4, CDK5, GSK3 beta , Bcr-ab1, Flt-3, c-Kit, PDGFR beta , Src, Mek1 and CK1; 2-[N'-(2,3-dibromo-8-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-c]azepin-4-ylidene)-hydrazino]-benzoic acid; antiinflammatory agent; autoimmune, neurological, cardiovasculal, hormone-related diseases |
| 05/28/2009 | US20090137554 1,4,5,6-TETRAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY |
| 05/28/2009 | US20090137553 Thiazepine Oxazolidinones as Antibacterial Agents |
| 05/28/2009 | US20090137552 Organic Compound |
| 05/28/2009 | US20090137551 Substituted Bicyclolactam Compounds |
| 05/28/2009 | US20090137550 Novel Compounds |
| 05/28/2009 | US20090137549 Novel compounds useful for the treatment of degenerative & inflamatory diseases |
| 05/28/2009 | US20090137548 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors |
| 05/28/2009 | US20090137547 Heterobicyclic metalloprotease inhibitors |
| 05/28/2009 | US20090137546 Anti-Hypercholesterolemic Compounds |
| 05/28/2009 | US20090137545 2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]acetamide derivatives such as 2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]-N-methyl-N-[[1-(2-methylpyridin-4-yl)piperidin-4-yl]methyl]acetamide |
| 05/28/2009 | US20090137544 Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients |
| 05/28/2009 | US20090137543 Method and compounds for modulating insulin production |
| 05/28/2009 | US20090137542 Alpha-glucosidase inhibitors from fungal hydroxylation of tibolone and hydroxytibolones |
| 05/28/2009 | US20090137541 Novel Series of Imidazolyl Substituted Steroidal and Indan-1-One Derivatives |
| 05/28/2009 | US20090137540 Compositions for the treatment of gastrointestinal inflammation |
| 05/28/2009 | US20090137539 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate |
| 05/28/2009 | US20090137538 Method of treating atrophic vaginitis |
| 05/28/2009 | US20090137537 Therapeutic gestagens for the treatment of premenstrual dysphoric disorder |
| 05/28/2009 | US20090137536 Method for treating and preventing hyperparathyroidism |
| 05/28/2009 | US20090137535 Substituted oxazolidinone derivatives |
| 05/28/2009 | US20090137534 Skin treatment compositions and methods |
| 05/28/2009 | US20090137533 Convenience Kit for Eyelid Treatment |
| 05/28/2009 | US20090137532 Aldolase-inhibiting aromatic compounds |